Interest Groups

WG on Eosinophilic Esophagitis

  • 2015-2017


    • Chairperson

    • Alex Straumann
    • Switzerland
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Secretary

    • Ingrid Terreehorst
    • The Netherlands
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    Members


    • Alfredo Lucendo
    • Spain
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Edoardo Savarino
    • Italy
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Antonella Cianferoni
    • USA
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Carina Venter
    • United Kingdom
    • This email address is being protected from spambots. You need JavaScript enabled to view it.

    • Alain Schoepfer
    • Switzerland
    • This email address is being protected from spambots. You need JavaScript enabled to view it.
    Last updated: 21 July 2017

WG on Eosinophilic Esophagitis - About Us

Eosinophilic esophagitis (EoE) is a chronic, immune-mediated inflammatory condition of the esophagus. It may occur in all ages with characteristic symptoms of esophageal dysfunction, while diagnosis is confirmed by endoscopic findings and a significant esophageal eosinophilia.

In adults, it is associated with difficulty in swallowing, food impaction, chest pain and stricture formation in the esophagus. In children, symptoms include vomiting and regurgitation, feeding disorders and oral aversion, food impaction and a general failure to thrive. Endoscopic findings that might signal eosinophilic esophagitis include rings, stricture, furrow or straight lines, white spots, and a small-caliber esophagus. However, endoscopy in patients with EoE may result without pathological findings.

The etiology of EoE is not known, however atopy is a risk factor. Most patients with EoE are allergic to inhalants and food allergens. But in 30% of patients, endoscopic exams turn up normal.

Treatment of EoE is mainly based on dietary restrictions and antiinflamatory medications, while endoscopical interventions are necessary in severe cases of esophageal stenosis.

The EoE WG intents to inform and update EAACI members on this diseases, to offer educational tools and organize educational meetings on EoE.
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel